title: Angiotensin receptor blockers: baseline therapy in hypertension?
authors.affiliation: St. Luke's Roosevelt Hospital and Columbia University, New York, NY 10019, USA. messerli.f@gmail.com
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
authors.forename: Sripal
authors.initials: S
authors.lastname: Bangalore
authors.forename: Frank
authors.initials: F
authors.lastname: Ruschitzka
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine